Here's what the Queen's Speech means for people with Parkinson's, their carers and families.
we announce the winners of our first volunteer awards
Previous top line results indicated that, while safe, Nilotinib failed to show benefit. The full results now show that there may be some potential benefits.
2019 was another exciting year of progress. Here are 8 of the highlights, and 8 ways you can still get involved.
As part of the Aligning Science Across Parkinson’s (ASAP) initiative, an ambitious global five-year programme was announced today to understand the genetic root of Parkinson’s.
Results have been shared from the US-based phase 2 clinical trial of nilotinib in people with moderate to advanced Parkinson's.
While safe and tolerable, the repurposed drug did not appear to have beneficial effects.
The Horsham and District local group is attempting to achieve big things with their 2019 single, ‘This Christmas Time’.
Researchers, funded by Parkinson's UK, have produced positive results in mice for a gene therapy treatment that directly targets the production of the alpha-synuclein protein.
Survey we supported shares findings that people with advanced or terminal illness support a change in the law on assisted dying
This week is Trustees’ Week, an annual event to showcase the great work trustees do for charities up and down the UK.